Invention Grant
US08173601B2 Activin-ActRIIa antagonists and uses for treating multiple myeloma
有权
Activin-ActRIIa拮抗剂和治疗多发性骨髓瘤的用途
- Patent Title: Activin-ActRIIa antagonists and uses for treating multiple myeloma
- Patent Title (中): Activin-ActRIIa拮抗剂和治疗多发性骨髓瘤的用途
-
Application No.: US12012525Application Date: 2008-02-01
-
Publication No.: US08173601B2Publication Date: 2012-05-08
- Inventor: John Knopf , Jasbir Seehra , Ravindra Kumar
- Applicant: John Knopf , Jasbir Seehra , Ravindra Kumar
- Applicant Address: US MA Cambridge
- Assignee: Acceleron Pharma, Inc.
- Current Assignee: Acceleron Pharma, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Ropes & Gray LLP
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C07K19/00
Abstract:
In certain aspects, the present invention provides compositions and methods for promoting bone growth and increasing bone density, as well as for the treatment of multiple myeloma.
Public/Granted literature
- US20090142333A1 Activin-actriia antagonists and uses for promoting bone growth in cancer patients Public/Granted day:2009-06-04
Information query
IPC分类:
